CO-0066

N/A

Report date: 2024/07/02 10:33:16

Base Information

Drug NameCO-0066
Drug Alias NameCO0066
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapy > Chimeric antigen receptor Macrophages therapy
Mechanisms of ActionMacrophage replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCellOrigin Technology (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCellOrigin Technology (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A